HY-15096-50mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
HY-15096-1mL
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-R03218A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p agomir
|
|
|
|
HY-R03218A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p agomir
|
|
|
|
HY-RI03218A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p antagomir
|
|
|
|
HY-RI03218A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p antagomir
|
|
|
|
HY-RI03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p inhibitor
|
|
|
|
HY-RI03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p inhibitor
|
|
|
|
HY-R03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03219A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p agomir
|
|
|
|
HY-R03219A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p agomir
|
|
|
|
HY-RI03219A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p antagomir
|
|
|
|
HY-RI03219A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p antagomir
|
|
|
|
HY-RI03219-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p inhibitor
|
|
|
|
HY-RI03219-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p inhibitor
|
|
|
|
HY-R03219-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03219-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|